Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
Establishing Asymchem’s first manufacturing footprint in Europe
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Subscribe To Our Newsletter & Stay Updated
